Anemia in Young Female: Workup and Management
In a young menstruating woman with anemia, start with oral iron supplementation (ferrous sulfate 200 mg three times daily) while simultaneously screening for celiac disease with tissue transglutaminase antibodies, and reserve bidirectional endoscopy for those over age 45-50, those with gastrointestinal symptoms, those with a strong family history of colorectal cancer, or those who fail to respond to iron therapy after 3-4 weeks.
Initial Diagnostic Workup
Laboratory Testing
Begin with a complete blood count and iron studies to confirm iron deficiency anemia:
- Hemoglobin <12 g/dL defines anemia in non-pregnant women 1, 2
- Ferritin <30 µg/L confirms iron deficiency 2
- Additional useful tests: MCV, transferrin saturation, serum iron 1, 3
Important caveat: Ferritin is an acute-phase reactant and can be falsely elevated during illness or inflammation, potentially masking iron deficiency 4. If ferritin is 30-100 µg/L with inflammation present, iron deficiency may still exist 3.
Assess Menstrual History
Document menstrual blood loss carefully, as this is the most common cause of IDA in young women, affecting 5-10% of menstruating women 5:
- Duration of menses (>7 days is concerning) 6
- Number of sanitary products used (>5 per day suggests heavy menstrual bleeding) 6
- Nighttime product changes required 6
- Passage of large clots 6
Screen for Celiac Disease
All young women with IDA should have celiac serology (tissue transglutaminase antibodies with IgA level to exclude IgA deficiency) 5, 7, 5. Celiac disease is present in up to 4% of premenopausal women with IDA 7.
Treatment Approach
First-Line: Oral Iron Therapy
Prescribe ferrous sulfate 200 mg three times daily 5. Alternatives include ferrous gluconate or ferrous fumarate, which are equally effective 5.
Key treatment principles:
- Hemoglobin should rise by 2 g/dL after 3-4 weeks 5
- Continue iron for 3 months after correction to replenish stores 5
- Consider adding ascorbic acid (250-500 mg twice daily) if response is poor 7
Common reasons for treatment failure:
When to Use Intravenous Iron
Reserve parenteral iron for 5, 7:
- Intolerance to at least two oral preparations
- Non-compliance with oral therapy
- Malabsorption (e.g., inflammatory bowel disease)
- Need for rapid correction
Note: IV iron carries risks of anaphylaxis and requires resuscitation facilities available 7. The rise in hemoglobin at 12 weeks is similar between oral and IV iron 7.
Gastrointestinal Investigation Strategy
Age-Based Approach
For women <45-50 years old without alarm symptoms:
- Upper endoscopy is NOT routinely indicated 5, 7, 5
- Celiac serology is sufficient for upper GI evaluation 5
- Colonoscopy is NOT routinely indicated 5
For women ≥45-50 years old:
- Bidirectional endoscopy is recommended (upper endoscopy with small bowel biopsy AND colonoscopy) 5, 7, 5
- The prevalence of GI malignancy increases significantly with age 7
Indications for Earlier Endoscopy (Any Age)
Perform bidirectional endoscopy in young women if 7, 8:
- Upper GI symptoms (dyspepsia, reflux, dysphagia)
- Lower GI symptoms (change in bowel habits, rectal bleeding)
- Strong family history of colorectal cancer (two first-degree relatives OR one first-degree relative diagnosed <50 years)
- Persistent IDA despite iron supplementation and correction of menstrual losses
- Failure to respond to oral iron after 4 weeks of compliant therapy
Evidence note: The prevalence of lower GI malignancy in asymptomatic premenopausal women with IDA is only 0.9% (95% CI 0.3-1.9%), and upper GI malignancy 0.2% (95% CI 0-0.9%) 8. However, colorectal cancer incidence is rising in younger cohorts 8.
Special Considerations
Ethnic Background
In women of African, Mediterranean, or Southeast Asian ancestry, if anemia does not respond to iron therapy, consider 1:
- Thalassemia minor
- Sickle cell trait
- Obtain MCV, RDW, and hemoglobin electrophoresis
Dietary Assessment
Evaluate for:
- Vegetarian/vegan diet (non-heme iron is poorly absorbed) 4
- No red meat consumption 4
- Use of H2-blockers or proton pump inhibitors (impair iron absorption) 9
Pregnancy Considerations
If pregnant 1:
- Start low-dose iron (30 mg/day) at first prenatal visit for prevention
- Treat IDA with 60-120 mg/day
- Refer if hemoglobin <9 g/dL or hematocrit <27%
Follow-Up Protocol
Monitor hemoglobin and red cell indices 5:
- Every 3 months for 1 year
- Then at 1 year
- Subsequently only if symptoms recur
Reassuring data: Iron deficiency does not recur in most patients in whom no cause is found after appropriate investigation 7, 5.
When to Investigate Further
Consider additional workup if 5:
- Hemoglobin and MCV cannot be maintained with intermittent iron supplementation
- Recurrent IDA despite treatment
- New symptoms develop
Critical pitfall: Do not perform routine screening with fecal occult blood testing—it is insensitive and non-specific in this context 5.